From New Jersey Economic Development Authority:
Join us to learn more about the state’s funding and incentive programs and to hear from New Jersey’s life sciences industry leaders who have benefitted from these important incentive funding programs.
Did you know Lawrenceville-based oncology company Celsion Corp. was awarded $11M in 2018 from New Jersey’s Net Operating Loss Program? The deadline to apply for this program is June 30th 2019 – so don’t miss out on this opportunity to learn more.
Did you know that New Jersey’s Angel Investor Tax Credit provides up to $25M in tax credits per calendar year to investors that invest in New Jersey companies?
There are also Federal tax programs with a cash component that may be available to NJ’s R&D companies.
The event is the latest in an ongoing series of biotechnology funding panel discussions hosted at the EDA’s CCIT Life Sciences incubator in North Brunswick.
Moderator – Eisner Amper, John Pennett
Celsion - Jeffrey Church, CFO
ScyNexis - Marco Tagleitti, CEO
NJEDA - Kathleen Coviello, Vice President
This event held in partnership with:
Bio NJ, NJ Tech Council, and the Commercialization Center for Innovative Technologies.